Literature DB >> 53554

24-hour control of intragastric acidity by cimetidine in duodenal-ulcer patients.

R E Pounder, J G Williams, G J Milton-Thompson, J J Misiewicz.   

Abstract

The effects of two dose regimens of cimetidine on 24 h intragastric acidity were investigated in six patients with duodenal ulcer. They received placebo capsules on the first day and cimetidine on the second day. Cimetidine 0-8 g/day decreased 24 h mean H+ activity by 55% but 1-6 g/day decreased it by 67%, the difference being due to a greater nocturnal decrease in the high-dose group. Intragastric pH remained below 2-0 for much of the treatment day but similar values were found in four post-vagotomy patients. Cimetidine 0-8-1-6 g/day results in a decrease of intragastric acidity that is compatible with successful medical treatment of duodenal ulceration.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 53554     DOI: 10.1016/s0140-6736(75)90434-1

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  32 in total

Review 1.  Drugs in the treatment of gastric and duodenal ulcer.

Authors:  M J Langman
Journal:  Drugs       Date:  1977-08       Impact factor: 9.546

Review 2.  Gastroenterology in the armed forces.

Authors:  G Milton-Thompson
Journal:  Gut       Date:  1989-11       Impact factor: 23.059

3.  Evaluation of two equivalent regimens (BID, QID) of cimetidine to raise intragastric pH over a 24-hour period in patients with duodenal ulcer.

Authors:  K Shiratori; S Watanabe; T Takeuchi
Journal:  Dig Dis Sci       Date:  1986-11       Impact factor: 3.199

4.  The preventive effect of cimetidine on producing stress ulcer in rats.

Authors:  K Sugimachi; S Sufian; T Matsumoto; T Nakamura; K Inokuchi
Journal:  Jpn J Surg       Date:  1978-09

5.  Optimal dose of oral omeprazole for maximal 24 hour decrease of intragastric acidity.

Authors:  B K Sharma; R P Walt; R E Pounder; M D Gomes; E C Wood; L H Logan
Journal:  Gut       Date:  1984-09       Impact factor: 23.059

6.  24-hour intragastric acidity and nocturnal acid secretion in patients with duodenal ulcer during oral administration of cimetidine and atropine.

Authors:  R E Pounder; R H Hunt; S H Vincent; G J Milton-Thompson; J J Misiewicz
Journal:  Gut       Date:  1977-02       Impact factor: 23.059

7.  Effects of eight weeks' continuous treatment with oral ranitidine and cimetidine on gastric acid secretion, pepsin secretion, and fasting serum gastrin.

Authors:  R Mohammed; R J Holden; J B Hearns; B M McKibben; K D Buchanan; G P Crean
Journal:  Gut       Date:  1983-01       Impact factor: 23.059

8.  Oxmetidine: clinical pharmacological studies with a new H2-receptor antagonist.

Authors:  J G Mills; P L Brunet; R Griffiths; R H Hunt; D Vincent; G J Milton-Thompson; W L Burland
Journal:  Gut       Date:  1982-02       Impact factor: 23.059

9.  Effect of prolonged cimetidine therapy on gastric acid secretion in man.

Authors:  G O Barbezat; S Bank
Journal:  Gut       Date:  1978-02       Impact factor: 23.059

Review 10.  Cimetidine: a review of its pharmacological properties and therapeutic efficacy in peptic ulcer disease.

Authors:  R N Brogden; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1978-02       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.